{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:22:02Z","timestamp":1774938122911,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010148","name":"Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda","doi-asserted-by":"publisher","award":["Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda"],"award-info":[{"award-number":["Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda"]}],"id":[{"id":"10.13039\/100010148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02405-3","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:51:50Z","timestamp":1774932710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of apoptotic genetic polymorphisms in prostate cancer susceptibility in a North West Spain population"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-7146","authenticated-orcid":false,"given":"N.","family":"L\u00f3pez-Trigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Caeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"P\u00e9rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rodr\u00edguez-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Agu\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Luis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2405_CR1","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.mgene.2021.100962","volume":"30","author":"R Akter","year":"2021","unstructured":"Akter R, Islam MS, Islam MS, Aziz MA, Hussain MS, Millat MS et al (2021) A case-control study investigating the association of TP53 rs1042522 and CDH1 rs16260 polymorphisms with prostate cancer risk. Meta Gene 30:100962. https:\/\/doi.org\/10.1016\/j.mgene.2021.100962","journal-title":"Meta Gene"},{"key":"2405_CR2","unstructured":"American Cancer Society (2024) American Cancer Society-Information and Resources about Prostate Cancer. Retrieved from http:\/\/www.cancer.org\/. Accessed 19 December 2024"},{"issue":"19","key":"2405_CR3","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1093\/hmg\/ddv203","volume":"24","author":"A Amin Al Olama","year":"2015","unstructured":"Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders et al (2015) Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet 24(19):5589\u20135602. https:\/\/doi.org\/10.1093\/hmg\/ddv203","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2405_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"Cancer J Clin"},{"issue":"1","key":"2405_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2407-13-356","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Cui X, Zhou H, Qin C, Cao Q, Ju X et al (2013) Functional promoter \u2013\u200931G\/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study. BMC Cancer 13(1):356. https:\/\/doi.org\/10.1186\/1471-2407-13-356","journal-title":"BMC Cancer"},{"issue":"5","key":"2405_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3390\/biomedicines11051404","volume":"11","author":"A Duncan","year":"2023","unstructured":"Duncan A, Nousome D, Ricks R, Kuo HC, Ravindranath L, Dobi A et al (2023) Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men. Biomedicines 11(5):1404. https:\/\/doi.org\/10.3390\/biomedicines11051404","journal-title":"Biomedicines"},{"issue":"5","key":"2405_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.acuroe.2011.06.005","volume":"35","author":"J Ferris-i-Tortajada","year":"2011","unstructured":"Ferris-i-Tortajada J, Garcia-i-Castell J, Berbel-Tornero O, Ortega-Garcia JA (2011) Constitutional risk factors in prostate cancer. Actas Urol Esp 35(5):282\u2013288. https:\/\/doi.org\/10.1016\/j.acuroe.2011.06.005","journal-title":"Actas Urol Esp"},{"issue":"12","key":"2405_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/cam4.555","volume":"4","author":"LB Gansmo","year":"2015","unstructured":"Gansmo LB, Romundstad P, Birkeland E, Hveem K, Vatten L, Knappskog S et al (2015) MDM4 SNP34091 (rs4245739) and its effect on breast-, colon\u2010, lung\u2010, and prostate cancer risk. Cancer Med 4(12):1901\u20131907. https:\/\/doi.org\/10.1002\/cam4.555","journal-title":"Cancer Med"},{"issue":"6","key":"2405_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.urolonc.2010.08.027","volume":"30","author":"GP George","year":"2012","unstructured":"George GP, Mandal RK, Kesarwani P, Sankhwar SN, Mandhani A, Mittal RD (2012) Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India. Urol Oncol: Semin Orig Inv 30(6):781\u2013789. https:\/\/doi.org\/10.1016\/j.urolonc.2010.08.027","journal-title":"Urol Oncol: Semin Orig Inv"},{"issue":"6","key":"2405_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","volume":"16","author":"S Goldar","year":"2015","unstructured":"Goldar S, Khaniani MS, Derakhshan SM, Baradaran B (2015) Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev 16(6):2129\u20132144","journal-title":"Asian Pac J Cancer Prev"},{"issue":"43","key":"2405_CR11","doi-asserted-by":"publisher","first-page":"75389","DOI":"10.18632\/oncotarget.17853","volume":"8","author":"Y Gui","year":"2017","unstructured":"Gui Y, Pan Q, Chen X, Xu S, Luo X, Chen L (2017) The association between obesity related adipokines and risk of breast cancer: a meta-analysis. Oncotarget 8(43):75389. https:\/\/doi.org\/10.18632\/oncotarget.17853","journal-title":"Oncotarget"},{"issue":"4","key":"2405_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/pros.10021","volume":"49","author":"WD Henner","year":"2001","unstructured":"Henner WD, Evans AJ, Hough KM, Harris EL, Lowe BA, Beer TM (2001) Association of codon 72 polymorphism of p53 with lower prostate cancer risk. Prostate 49(4):263\u2013266. https:\/\/doi.org\/10.1002\/pros.10021","journal-title":"Prostate"},{"issue":"4","key":"2405_CR13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.17843\/rpmesp.2015.324.1771","volume":"32","author":"D Herrera-Covarrubias","year":"2015","unstructured":"Herrera-Covarrubias D, Coria-Avila GA, Fern\u00e1ndez-Pomares C, Aranda-Abreu GE, Manzo Denes J, Hern\u00e1ndez ME (2015) La obesidad como factor de riesgo en el desarrollo de c\u00e1ncer. Rev Peru Med Exp y Salud P\u00fablica 32(4):766\u2013776","journal-title":"Rev Peru Med Exp y Salud P\u00fablica"},{"issue":"5","key":"2405_CR14","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2741\/1891","volume":"11","author":"AW Hsing","year":"2006","unstructured":"Hsing AW, Chokkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11(5):1388\u20131413","journal-title":"Front Biosci"},{"issue":"12","key":"2405_CR15","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1158\/1055-9965.2217.13.12","volume":"13","author":"SP Huang","year":"2004","unstructured":"Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ et al (2004) p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Cancer Epidemiol Biomarkers Prev 13(12):2217\u20132224. https:\/\/doi.org\/10.1158\/1055-9965.2217.13.12","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4S","key":"2405_CR16","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/j.juro.2011.02.838","volume":"185","author":"M Hyndman","year":"2011","unstructured":"Hyndman M, Xu J, Zheng S, Isaacs W, Pavlovich C (2011) The Bcl-2-938\u00a0C genotype is more prevalent in patients with aggressive disease and a family history of prostate cancer. J Urol 185(4S):e482\u2013e483. https:\/\/doi.org\/10.1016\/j.juro.2011.02.838","journal-title":"J Urol"},{"key":"2405_CR17","doi-asserted-by":"publisher","unstructured":"Jiao Y, Jiang Z, Wu Y, Chen X, Xiao X, Yu H (2016) A functional polymorphism (rs937283) in the MDM2 promoter region is associated with poor prognosis of retinoblastoma in Chinese Han population. Sci Rep 6(1): 1\u201311. https:\/\/doi.org\/10.1038\/srep31240","DOI":"10.1038\/srep31240"},{"key":"2405_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.17179\/excli2018-1234","volume":"17","author":"M Karimian","year":"2018","unstructured":"Karimian M, Aftabi Y, Mazoochi T, Babaei F, Khamechian T, Boojari H, Nikzad H (2018) Survivin polymorphisms and susceptibility to prostate cancer: A genetic association study and an in silico analysis. EXCLI J 17:479\u2013491. https:\/\/doi.org\/10.17179\/excli2018-1234","journal-title":"EXCLI J"},{"issue":"11","key":"2405_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/pros.20784","volume":"68","author":"AS Kibel","year":"2008","unstructured":"Kibel AS, Jin CH, Klim A, Luly J, Roehl K, Wu WS, Suarez BK (2008) Association between polymorphisms in cell cycle genes and advanced prostate carcinoma. Prostate 68(11):1179\u20131186. https:\/\/doi.org\/10.1002\/pros.20784","journal-title":"Prostate"},{"issue":"3","key":"2405_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.pcan.4500884","volume":"9","author":"LR Kidd","year":"2006","unstructured":"Kidd LR, Coulibaly A, Templeton TM, Chen W, Long LO, Mason T et al (2006) Germline BCL-2 sequence variants and inherited predisposition to prostate cancer. Prostate Cancer Prostatic Dis 9(3):284\u2013292. https:\/\/doi.org\/10.1038\/sj.pcan.4500884","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2405_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biomedicines12010097","volume":"12","author":"JW Kim","year":"2024","unstructured":"Kim JW, Kim JH, Lee YJ (2024) The role of adipokines in tumor progression and its association with obesity. Biomedicines 12(1):97. https:\/\/doi.org\/10.3390\/biomedicines12010097","journal-title":"Biomedicines"},{"issue":"7","key":"2405_CR22","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1007\/s13277-016-5035-9","volume":"37","author":"Y Kiraz","year":"2016","unstructured":"Kiraz Y, Adan A, Kartal Yandim M, Baran Y (2016) Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biol 37(7):8471\u20138486. https:\/\/doi.org\/10.1007\/s13277-016-5035-9","journal-title":"Tumor Biol"},{"issue":"4","key":"2405_CR23","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s12253-020-00839-7","volume":"26","author":"N Kotarac","year":"2020","unstructured":"Kotarac N, Dobrijevic Z, Matijasevic S, Savic-Pavicevic D, Brajuskovic G (2020) Association of KLK3, VAMP8 and MDM4 genetic variants within microRNA binding sites with prostate cancer: Evidence from Serbian population. Pathol Oncol Res 26(4):2409\u20132423. https:\/\/doi.org\/10.1007\/s12253-020-00839-7","journal-title":"Pathol Oncol Res"},{"issue":"22","key":"2405_CR24","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.3390\/ijms252212137","volume":"25","author":"KT Liermann-Wooldrik","year":"2024","unstructured":"Liermann-Wooldrik KT, Kosmacek EA, Oberley-Deegan RE (2024) Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression. Int J Mol Sci 25(22):12137. https:\/\/doi.org\/10.3390\/ijms252212137","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2405_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/sj.pcan.4501002","volume":"11","author":"L Lima","year":"2008","unstructured":"Lima L, Morais A, Lobo F, Calais-da-Silva FM, Calais-da-Silva FE, Medeiros R (2008) Association between FAS polymorphism and prostate cancer development. Prostate Cancer Prostatic Dis 11(1):94\u201398. https:\/\/doi.org\/10.1038\/sj.pcan.4501002","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"2405_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4321\/S0004-06142009000200003","volume":"62","author":"CM L\u00f3pez Fontana","year":"2009","unstructured":"L\u00f3pez Fontana CM, Maselli Artola ME, Milta M\u00f3naco ND, Recalde Rinc\u00f3n GM, Vanrell Rodriguez MC, Uvilla Recupero A et al (2009) Influencia de la leptina y la adiponectina sobre el c\u00e1ncer de pr\u00f3stata. Arch Esp Urol 62(2):103\u2013108","journal-title":"Arch Esp Urol"},{"key":"2405_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.gene.2018.08.073","volume":"679","author":"N L\u00f3pez-Trigo","year":"2018","unstructured":"L\u00f3pez-Trigo N, Aguin N, Castuera IP, Rodr\u00edguez-Alonso A, Luis JR, Caeiro B (2018) Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain). Gene 679:126\u2013132. https:\/\/doi.org\/10.1016\/j.gene.2018.08.073","journal-title":"Gene"},{"issue":"6","key":"2405_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/pros.21098","volume":"70","author":"J Lubahn","year":"2010","unstructured":"Lubahn J, Berndt SI, Jin CH, Klim A, Luly J, Wu WS et al (2010) Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate 70(6):646\u2013653. https:\/\/doi.org\/10.1002\/pros.21098","journal-title":"Prostate"},{"issue":"5","key":"2405_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.urolonc.2010.05.006","volume":"30","author":"RK Mandal","year":"2012","unstructured":"Mandal RK, Mittal RD (2012) Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population? Urol Oncol. Semin Orig Inv 30(5):555\u2013561. https:\/\/doi.org\/10.1016\/j.urolonc.2010.05.006","journal-title":"Semin Orig Inv"},{"issue":"1","key":"2405_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.urolonc.2010.09.011","volume":"31","author":"A Meyer","year":"2013","unstructured":"Meyer A, Coinac I, Bogdanova N, Dubrowinskaja N, Turmanov N, Haubold S et al (2013) Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. Urol Oncol: Semin Orig Inv 31(1):74\u201381. https:\/\/doi.org\/10.1016\/j.urolonc.2010.09.011","journal-title":"Urol Oncol: Semin Orig Inv"},{"issue":"1","key":"2405_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.eururo.2007.03.054","volume":"52","author":"T Mistry","year":"2007","unstructured":"Mistry T, Digby JE, Desai KM, Randeva HS (2007) Obesity and prostate cancer: a role for adipokines. Eur Urol 52(1):46\u201353. https:\/\/doi.org\/10.1016\/j.eururo.2007.03.054","journal-title":"Eur Urol"},{"issue":"2","key":"2405_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.arcmed.2011.03.001","volume":"42","author":"RD Mittal","year":"2011","unstructured":"Mittal RD, George GP, Mishra J, Mittal T, Kapoor R (2011) Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India. Arch Med Res 42(2):122\u2013127. https:\/\/doi.org\/10.1016\/j.arcmed.2011.03.001","journal-title":"Arch Med Res"},{"issue":"1","key":"2405_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/dna.2011.1285","volume":"31","author":"RD Mittal","year":"2012","unstructured":"Mittal RD, Mittal T, Singh AK, Mandal R (2012) Association of caspases with an increased prostate cancer risk in north Indian population. DNA Cell Biol 31(1):67\u201373. https:\/\/doi.org\/10.1089\/dna.2011.1285","journal-title":"DNA Cell Biol"},{"key":"2405_CR34","first-page":"1","volume":"8876\u2013006","author":"P Oeth","year":"2005","unstructured":"Oeth P, Beaulieu M, Park C, Kosman D, del Mistro G, van Den Boom D, Jurinke C (2005) iPLEXTM Assay: Increased Plexing Efficiency and Flexibility for MassARRAY \u00ae System Through Single Base Primer Extension with Mass-Modified Terminators. Sequenom 8876\u2013006:1\u201312","journal-title":"Sequenom"},{"issue":"3","key":"2405_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1745-7262.2006.00135.x","volume":"8","author":"LA Qui\u00f1ones","year":"2006","unstructured":"Qui\u00f1ones LA, Irarr\u00e1zabal CE, Rojas CR, Orellana CE, Acevedo C, Huidobro C et al (2006) Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J Androl 8(3):349\u2013355. https:\/\/doi.org\/10.1111\/j.1745-7262.2006.00135.x","journal-title":"Asian J Androl"},{"issue":"2","key":"2405_CR36","first-page":"467","volume":"57","author":"GD R\u0103d\u0103voi","year":"2016","unstructured":"R\u0103d\u0103voi GD, Pricop C, Jinga V, Mate\u015f D, R\u0103doi VE, Jinga M et al (2016) A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population. Rom J Morphol Embryol 57(2):467\u2013475","journal-title":"Rom J Morphol Embryol"},{"key":"2405_CR37","unstructured":"Rexistro galego de tumores (REGAT). Incidencia, mortalidade e supervivencia ao cancro en Galicia no ano 2022 (2023) Conseller\u00eda de Sanidade. https:\/\/www.sergas.es\/Saude-publica\/Documents\/7322\/Informe%202022_REGAT.pdf"},{"issue":"16","key":"2405_CR38","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/pros.21209","volume":"70","author":"L Ricks-Santi","year":"2010","unstructured":"Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, McLauchlin A, Josey D et al (2010) p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate 70(16):1739\u20131745. https:\/\/doi.org\/10.1002\/pros.21209","journal-title":"Prostate"},{"issue":"4","key":"2405_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000326767","volume":"78","author":"A Rogler","year":"2011","unstructured":"Rogler A, Rogenhofer M, Borchardt A, Lunz JC, Knoell A, Hofstaedter F et al (2011) P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype. Pathobiology 78(4):193\u2013200. https:\/\/doi.org\/10.1159\/000326767","journal-title":"Pathobiology"},{"issue":"10","key":"2405_CR40","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/pros.21328","volume":"71","author":"P Shao","year":"2011","unstructured":"Shao P, Ding Q, Qin C, Wang M, Tang J, Zhu J et al (2011) Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. Prostate 71(10):1122\u20131130. https:\/\/doi.org\/10.1002\/pros.21328","journal-title":"Prostate"},{"issue":"5","key":"2405_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/br.2015.496","volume":"3","author":"MK Sivo\u0148ov\u00e1","year":"2015","unstructured":"Sivo\u0148ov\u00e1 MK, Vil\u010dkov\u00e1 M, Kliment J, Mahmood S, Jure\u010dekov\u00e1 J, Du\u0161enkov\u00e1 S et al (2015) Association of p53 and p21 polymorphisms with prostate cancer. Biomed Rep 3(5):707\u2013714. https:\/\/doi.org\/10.3892\/br.2015.496","journal-title":"Biomed Rep"},{"issue":"1","key":"2405_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/sj.bjc.6604441","volume":"99","author":"R Stoehr","year":"2008","unstructured":"Stoehr R, Hitzenbichler F, Kneitz B, Hammerschmied CG, Burger M, Tannapfel A, Hartmann A (2008) Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics. Br J Cancer 99(1):78\u201382. https:\/\/doi.org\/10.1038\/sj.bjc.6604441","journal-title":"Br J Cancer"},{"issue":"21","key":"2405_CR43","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1158\/1078-0432.CCR-10-1261","volume":"16","author":"T Sun","year":"2010","unstructured":"Sun T, Lee GS, Oh WK, Pomerantz M, Yang M, Xie W et al (2010) Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population. Clin Cancer Res 16(21):5244\u20135251. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1261","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2405_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1159\/000071162","volume":"10","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H et al (2003) A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J Biomed Sci 10(4):430\u2013435. https:\/\/doi.org\/10.1159\/000071162","journal-title":"J Biomed Sci"},{"key":"2405_CR45","unstructured":"The 1000 Genomes Project Consortium (2015) A global reference for human genetic variation. Nature 526(7571): 68\u201374. Retrieved from https:\/\/www.internationalgenome.org\/ Accessed 22 April 2023"},{"issue":"14","key":"2405_CR46","doi-asserted-by":"publisher","first-page":"e179570","DOI":"10.1172\/JCI179570","volume":"134","author":"X Tian","year":"2024","unstructured":"Tian X, Srinivasan PR, Tajiknia V, Uruchurtu AFSS, Seyhan AA, Carneiro BA et al (2024) Targeting apoptotic pathways for cancer therapy. J Clin Invest 134(14):e179570. https:\/\/doi.org\/10.1172\/JCI179570","journal-title":"J Clin Invest"},{"issue":"2","key":"2405_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cancergencyto.2010.02.014","volume":"202","author":"B Xu","year":"2010","unstructured":"Xu B, Xu Z, Cheng G, Min ZC, Mi Y, Zhang ZZ et al (2010) Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese. Cancer Genet Cytogenet 202(2):76\u201381. https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.02.014","journal-title":"Cancer Genet Cytogenet"},{"issue":"22","key":"2405_CR48","doi-asserted-by":"publisher","first-page":"31825","DOI":"10.18632\/oncotarget.3923","volume":"7","author":"L Xue","year":"2016","unstructured":"Xue L, Han X, Liu R, Wang Z, Li H, Chen Q et al (2016) MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer. Oncotarget 7(22):31825\u201331831. https:\/\/doi.org\/10.18632\/oncotarget.3923","journal-title":"Oncotarget"},{"key":"2405_CR49","doi-asserted-by":"crossref","unstructured":"Yilmaz SG, Yencilek F, Yildirim A, Yencilek E, Isbir T (2017) Effects of caspase 9 gene polymorphism in patients with prostate cancer. in vivo 31(2): 205\u2013208","DOI":"10.21873\/invivo.11046"},{"issue":"23","key":"2405_CR50","doi-asserted-by":"publisher","first-page":"12928","DOI":"10.3390\/ijms252312928","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xu J, Long Y, Maimaitjiang A, Su Z, Li W et al (2024) Unraveling the guardian: p53\u2019s multifaceted role in the DNA damage response and tumor treatment strategies. Int J Mol Sci 25(23):12928. https:\/\/doi.org\/10.3390\/ijms252312928","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02405-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02405-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02405-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:52:02Z","timestamp":1774932722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02405-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2405"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02405-3","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this paper declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Research have been performed in accordance with the Declaration of Helsinki. The study was approved by the Galician Ethics Committee (Comit\u00e9 \u00c9tico de Galicia) and all participants were asked to provide their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"80"}}